Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.…
Envoy Medical Expands Intellectual Property Portfolio to 99 Patents with New U.S. and Hong Kong Patent Grants
Envoy Medical (NASDAQ: COCH) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 43 employees.
The shares were at 6.700 USD on 20 November 2026, down 4.6% over 52 weeks. Its 52-week range is 3.630 USD to 9.540 USD: the price is 29.8% below the high and 84.6% above the low.
Its market capitalisation is 51.89M USD.
Envoy Medical reports return on equity of 201.9% and revenue up 57.1% year over year.
It holds more cash than debt, a net cash position of 13.79M USD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 3 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 19.67 USD is 193.5% above the current price.